VINCENT: Validated Interaction Network for Cross-drug Explanation of Therapeutics
Mirrored from arXiv — Machine Learning for archival readability. Support the source by reading on the original site.
Computer Science > Machine Learning
Title:VINCENT: Validated Interaction Network for Cross-drug Explanation of Therapeutics
Abstract:Drug synergy prediction estimates whether two drugs produce a stronger joint effect than expected from their individual activities. For drug combination discovery, a single synergy score is often not enough: researchers also need to know which molecular regions jointly drive the prediction. We study motif-pair synergy explanation, which identifies pairs of chemically coherent regions, one from each drug, that jointly contribute to predicted synergy. Existing interpretable synergy models expose atom- or substructure-level signals, but their explanations are built into the predictor architecture, and none validates cross-drug region scores under repeated perturbations or feeds that evidence back to refine the explanation. A reliable motif-pair explanation should instead be chemically coherent, perturbation-stable, and aligned with predictor behavior. We introduce VINCENT (Validated Interaction Network for Cross-drug Explanation of Therapeutics), a post-training framework for a fixed interaction-aware synergy predictor. VINCENT extracts atom-pair evidence from attention and gradient signals, groups atoms into chemically coherent motifs, and validates candidate motif pairs through repeated local perturbations. The validated evidence is fed back to refine motif assignments, yielding explanations that satisfy these three criteria. On a 25-pair literature-annotated subset, VINCENT achieves a mean motif recall of 0.826 (95% CI: 0.78-0.87), compared with 0.49-0.66 for baselines. Across all 71 test pairs, its validated interaction scores yield a TP/TN separation of 3.36. These results show that closed-loop perturbation validation recovers literature-supported molecular regions more accurately than existing alternatives while producing cross-drug interaction scores that better reflect predictor behavior.
| Comments: | 18 pages, 4 figures |
| Subjects: | Machine Learning (cs.LG); Artificial Intelligence (cs.AI) |
| Cite as: | arXiv:2608.25841 [cs.LG] |
| (or arXiv:2608.25841v1 [cs.LG] for this version) | |
| https://doi.org/10.48550/arXiv.2608.25841
arXiv-issued DOI via DataCite (pending registration)
|
Submission history
From: Fan-Sheng Chuang [view email][v1] Wed, 26 Aug 2026 14:18:35 UTC (1,016 KB)
Access Paper:
- View PDF
- HTML (experimental)
- TeX Source
References & Citations
Bibliographic and Citation Tools
Code, Data and Media Associated with this Article
Demos
Recommenders and Search Tools
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
More from arXiv — Machine Learning
-
SLM-Conditioned Hierarchical Relation Routing for Labeled Property Graph Learning
Aug 28
-
NeuronFuzz: Safety Neuron Guided Fuzzing for LLM Safety Evaluation
Aug 28
-
Pruning Binarized Neural Networks: A Dedicated Framework and Globally Weighted Algorithms
Aug 28
-
Muon with Finite Newton-Schulz: The Smoothing Benefit in Nonsmooth Nonconvex Optimization
Aug 28
Discussion (0)
Sign in to join the discussion. Free account, 30 seconds — email code or GitHub.
Sign in →No comments yet. Sign in and be the first to say something.